1. Home
  2. Author
  3. Gantz I

Gantz I

References (2)

Title : A Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of Adding Omarigliptin to Insulin Therapy in Japanese Patients with Type 2 Diabetes and Inadequate Glycemic Control - Kadowaki_2021_Diabetes.Obes.Metab__
Author(s) : Kadowaki T , Seino Y , Kaku K , Okamoto T , Kameya M , Sato A , Hirano T , Oshima N , Gantz I , O'Neill EA , Engel SS
Ref : Diabetes Obes Metab , : , 2021
Abstract : Kadowaki_2021_Diabetes.Obes.Metab__
ESTHER : Kadowaki_2021_Diabetes.Obes.Metab__
PubMedSearch : Kadowaki_2021_Diabetes.Obes.Metab__
PubMedID: 33512755

Title : A randomized, placebo-controlled clinical trial evaluating the safety and efficacy of the once-weekly DPP-4 inhibitor omarigliptin in patients with type 2 diabetes mellitus inadequately controlled by glimepiride and metformin - Lee_2017_BMC.Endocr.Disord_17_70
Author(s) : Lee SH , Gantz I , Round E , Latham M , O'Neill EA , Ceesay P , Suryawanshi S , Kaufman KD , Engel SS , Lai E
Ref : BMC Endocr Disord , 17 :70 , 2017
Abstract : Lee_2017_BMC.Endocr.Disord_17_70
ESTHER : Lee_2017_BMC.Endocr.Disord_17_70
PubMedSearch : Lee_2017_BMC.Endocr.Disord_17_70
PubMedID: 29110647